Drugs / tiludronic acid
tiludronic acid
also known as
Acide tiludronique · Acido tiludronico · Skelid · SR 41319 · SR 41319B · Tiludronate · TILUDRONATE DISODIUM · Tiludronate disodium anhydrous · +2 more
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01617057 | May 2012 → Mar 2016 | otosclerosis | Assistance Publique - Hôpitaux de Paris | Terminated | No outcome recorded |
Evidence & citations 12 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | tiludronic acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01617057 ↗ |
| Known as | Acide tiludronique | ChEMBL registry synonym — accepted as the source's own label CHEMBL1350 ↗ |
| Known as | Acido tiludronico | ChEMBL registry synonym — accepted as the source's own label CHEMBL1350 ↗ |
| Known as | Skelid | “The aim of this study is to assess the efficacy of a biphosphonate (tiludronic acid, Skelid®, Sanofi-Aventis) in the treatment of inner ear involvement in advanced otosclerosis” NCT01617057 ↗ |
| Known as | SR 41319 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1350 ↗ |
| Known as | SR 41319B | ChEMBL registry synonym — accepted as the source's own label CHEMBL1350 ↗ |
| Known as | Tiludronate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1350 ↗ |
| Known as | TILUDRONATE DISODIUM | ChEMBL registry synonym — accepted as the source's own label CHEMBL1350 ↗ |
| Known as | Tiludronate disodium anhydrous | ChEMBL registry synonym — accepted as the source's own label CHEMBL1350 ↗ |
| Known as | Tiludronate sodium | ChEMBL registry synonym — accepted as the source's own label CHEMBL1350 ↗ |
| Known as | Tiludronic acid disodium salt | ChEMBL registry synonym — accepted as the source's own label CHEMBL1350 ↗ |
| Modality | Small molecule | — CHEMBL1350 ↗ |